Keywords: USA, GAO, PharmAthene, SparVax, Anthrax vaccine contract

US Government Accountability Office rules PharmAthene can keep $78 million SparVax contract

Article | 10 June 2010

Maryland, USA-based biodefense specialist PharmAthene got a boost yesterday, when the Government Accountability Office (GAO) denied a competitor's protest, challenging ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

PharmAthene

Go to company listing

Related Drugs

SparVax

Go to drug listing